Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Granules India Ltd.
NSE: GRANULES
|
BSE: 532482
|
ISIN: INE101D01020
|
Industry: Pharmaceuticals
US FDA Approval
|
Strong Performer, Getting Expensive
614.8000
14.05
(
2.34
%)
NSE
Dec 23, 2025
15:31 PM
Near 52W High of ₹621.10
Volume:
3.6M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Granules India Ltd.
31 Jan 2019
US FDA Approval
614.80
2.34%
BP Equities Granules India Ltd Q3FY19 Result Upda
Buy:
Granules India Ltd.
by
BP Wealth
Target: 146
Target
BP Wealth
Granules India Ltd. is trading above all available SMAs
More from Granules India Ltd.
Recommended
Five stocks to buy from analysts this week - December 23, 2025
The Baseline |
23 Dec 2025, 06:05PM
Market closes flat, dragged down by losses in IT & telco stocks
Trendlyne Marketwatch |
23 Dec 2025, 03:56PM
Granules: Will the record-breaking numbers sustain for this API pharmaceutical company?
|
30 Oct 2020